Teleflex Stock (NYSE:TFX)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$235.22

52W Range

$190.49 - $257.85

50D Avg

$240.80

200D Avg

$226.91

Market Cap

$9.47B

Avg Vol (3M)

$347.70K

Beta

1.16

Div Yield

$1.36 (0.68%)

TFX Company Profile


Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

14,500

IPO Date

Mar 17, 1980

Website

TFX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Anesthesia$389.96M$388.89M$380.14M
Surgical$427.36M$392.92M$377.76M
Vascular Access$708.04M$683.61M$700.24M
Other$291.90M$285.15M$336.58M
Interventional$511.43M$445.02M$427.50M
Interventional Urology$319.79M$322.83M$341.66M
Oem-$272.62M$245.68M

Fiscal year ends in Dec 23 | Currency in USD

TFX Financial Summary


Dec 23Dec 22Dec 21
Revenue$2.97B$2.79B$2.81B
Operating Income$357.57M$499.73M$628.10M
Net Income$356.33M$363.14M$485.37M
EBITDA$357.57M$745.02M$797.37M
Basic EPS$7.53$7.74$10.38
Diluted EPS$7.53$7.68$10.23

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 01, 24 | 3:30 PM
Q1 24May 02, 24 | 12:00 AM
Q4 23Feb 22, 24 | 12:11 PM

Peer Comparison


TickerCompany
MMSIMerit Medical Systems, Inc.
COOThe Cooper Companies, Inc.
WSTWest Pharmaceutical Services, Inc.
BDXBecton, Dickinson and Company
HOLXHologic, Inc.
ALCAlcon Inc.
RMDResMed Inc.
NVSTEnvista Holdings Corporation
ANGOAngioDynamics, Inc.
HAEHaemonetics Corporation
ICUIICU Medical, Inc.
ATRAptarGroup, Inc.